Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months: A Double-blind, Randomized Clinical Noninferiority Trial

IMPORTANCE: Pneumonia is the leading infectious killer of children. Rigorous evidence supporting antibiotic treatment of children with nonsevere fast-breathing pneumonia in low-resource African settings is lacking. OBJECTIVE: To assess whether treatment with placebo for nonsevere fast-breathing pneu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ginsburg, Amy Sarah, Mvalo, Tisungane, Nkwopara, Evangelyn, McCollum, Eric D., Ndamala, Chifundo B., Schmicker, Robert, Phiri, Ajib, Lufesi, Norman, Izadnegahdar, Rasa, May, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2018
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583426/
https://www.ncbi.nlm.nih.gov/pubmed/30419120
http://dx.doi.org/10.1001/jamapediatrics.2018.3407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583426/
https://www.ncbi.nlm.nih.gov/pubmed/30419120
http://dx.doi.org/10.1001/jamapediatrics.2018.3407

Ejemplares similares